Cargando…

The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses

BACKGROUND: MEDI8852 is a novel monoclonal antibody (mAb) that neutralizes both group I and group II influenza A viruses (IAVs) in vitro. We evaluated whether MEDI8852 was effective for prophylaxis and therapy against representative group I (H5N1) and group II (H7N9) pandemic IAVs in mice and ferret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paules, Catharine I, Lakdawala, Seema, McAuliffe, Josephine M, Paskel, Myeisha, Vogel, Leatrice, Kallewaard, Nicole L, Zhu, Qing, Subbarao, Kanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853468/ https://www.ncbi.nlm.nih.gov/pubmed/28633457 http://dx.doi.org/10.1093/infdis/jix292

Ejemplares similares

The soft palate is an important site of adaptation for transmissible influenza viruses
por: Lakdawala, Seema S., et al.
Publicado: (2015)

Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge
por: Baz, Mariana, et al.
Publicado: (2015)

Eurasian-Origin Gene Segments Contribute to the Transmissibility, Aerosol Release, and Morphology of the 2009 Pandemic H1N1 Influenza Virus
por: Lakdawala, Seema S., et al.
Publicado: (2011)

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys
por: McAuliffe, Josephine, et al.
Publicado: (2004)

Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
por: Houser, Katherine V., et al.
Publicado: (2016)

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
por: Bisht, Himani, et al.
Publicado: (2005)

Optimal Duration of Systemic Corticosteroids in Coronavirus Disease 2019 Treatment: A Systematic Review and Meta-analysis
por: Ssentongo, Paddy, et al.
Publicado: (2023)

Antibody Pressure by a Human Monoclonal Antibody Targeting the 2009 Pandemic H1N1 Virus Hemagglutinin Drives the Emergence of a Virus with Increased Virulence in Mice
por: O’Donnell, Christopher D., et al.
Publicado: (2012)

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
por: Kapadia, Sagar U., et al.
Publicado: (2005)

Medi-wiki worries?
por: Mason, Fred
Publicado: (2009)

Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans
por: Zhong, Weimin, et al.
Publicado: (2016)

MediNet: transfer learning approach with MediNet medical visual database
por: Reis, Hatice Catal, et al.
Publicado: (2023)

Porosity, Powder X-Ray Diffraction Patterns, Skeletal Density, and Thermal Stability of NIST Zeolitic Reference Materials RM 8850, RM 8851, and RM 8852
por: Nguyen, Huong Giang T., et al.
Publicado: (2022)

Comparison of Serum Hemagglutinin and Neuraminidase Inhibition Antibodies After 2010–2011 Trivalent Inactivated Influenza Vaccination in Healthcare Personnel
por: Laguio-Vila, Maryrose R., et al.
Publicado: (2014)

The Critical Interspecies Transmission Barrier at the Animal–Human Interface
por: Subbarao, Kanta
Publicado: (2019)

Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins
por: Tussey, Lynda, et al.
Publicado: (2016)

Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance
por: Nicholson, Suellen, et al.
Publicado: (2021)

Influenza hemagglutinin membrane anchor
por: Benton, Donald J., et al.
Publicado: (2018)

Art, ciéncia i medi natural.
Publicado: (1994)

Medie and Info-pubmed: 2010 update
por: Ohta, Tomoko, et al.
Publicado: (2010)

DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial
por: Houser, Katherine V., et al.
Publicado: (2018)

Overall Vertical Transmission of Hepatitis C Virus, Transmission Net of Clearance, and Timing of Transmission
por: Ades, Anthony E, et al.
Publicado: (2022)

Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines
por: Sutton, Troy C., et al.
Publicado: (2017)

In Vivo Imaging of Influenza Virus Infection in Immunized Mice
por: Czakó, Rita, et al.
Publicado: (2017)

MediVisión 3.2 para Windows.

Chocolate in History: Food, Medicine, Medi-Food
por: Lippi, Donatella
Publicado: (2013)

Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets
por: Suguitan, Amorsolo L, et al.
Publicado: (2006)

SARS Vaccine Protective in Mice
por: Stadler, Konrad, et al.
Publicado: (2005)

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
por: Wright, Peter F., et al.
Publicado: (2016)

Physicochemical properties of transmissible gastroenteritis virus hemagglutinin
por: Noda, M., et al.
Publicado: (1988)

Higher congenital transmission rate of Trypanosoma cruzi associated with family history of congenital transmission
por: Danesi, Emmaría, et al.
Publicado: (2020)

Animal models and vaccines for SARS-CoV infection
por: Roberts, Anjeanette, et al.
Publicado: (2008)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
por: Sobhanie, Mahdee, et al.
Publicado: (2016)

Disease Transmission by Patients With Subclinical Tuberculosis
por: Nguyen, Hai Viet, et al.
Publicado: (2023)

Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
por: Vogel, Leatrice N., et al.
Publicado: (2007)

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
por: Bukreyev, Alexander, et al.
Publicado: (2004)

Challenging the Cost Effectiveness of Medi-Cal Managed Care
por: Riner, R. Myles
Publicado: (2009)

Targeting CD73 in the tumor microenvironment with MEDI9447
por: Hay, Carl M., et al.
Publicado: (2016)

Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria Transmission
por: Challenger, Joseph D, et al.
Publicado: (2023)

Malaria Transmission Dynamics in a High-Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-Lumefantrine in an Asymptomatic Population
por: Andagalu, Ben, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l0aj04sel9296uv4brc8h109s8